Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: TAMI CHAPPELL / Contributor

The Trump administration is cutting the Centers for Disease Control and Prevention out of the process of collecting coronavirus data, The New York Times reports.

Why it matters: The new database will not be open to the public, according to the Times, and comes amid repeated efforts by the Trump administration to sideline the CDC.

Details: The White House told hospitals to stop reporting key data about their patients to the CDC, and to instead feed it into a new system that will flow directly to the Health and Human Services Department, which oversees the CDC.

  • The change was designed to help the White House's coronavirus task force allocate resources, officials told the Times.
  • But experts said they're worried that the new system will make it harder for people outside the White House to track the pandemic.

Between the lines: Experts told the NYT that the CDC's data collection systems are flawed, but some questioned whether the administration's new system would be significantly more efficient, on top of their questions about its transparency.

  • The CDC "will certainly participate" in the new process, but "will simply no longer control it," HHS spokesperson Michael Caputo told the Times.

Context: The CDC is increasingly under fire from the White House and its Republican allies.

  • President Trump and Vice President Pence both criticized CDC guidance that called for opening schools only with extensive social distancing measures in place.
  • Trump and senior White House officials previously complained about the CDC's decision to include "presumptive" coronavirus deaths — people who died after experiencing the symptoms of coronavirus, but had not been tested for it — in the official death tally.
  • Politico reported last month that the White House was looking to lay the blame for the coronavirus response on the CDC, potentially including "narrowing the mission of the agency or trying to embed more political appointees."

Go deeper

Updated Oct 22, 2020 - World

France becomes 2nd Western European country to top 1M coronavirus cases

French President Emmanuel Macron at the Seine Saint Denis prefecture headquarters in Paris, on Tuesday. Photo: Ludovic Marin/POOL/AFP via Getty Images

France has become the second country in Western Europe to surpass 1 million COVID-19 cases, Johns Hopkins University data shows

The big picture: France had reported 1,000,369 cases and 34,075 deaths from the coronavirus by Thursday morning, per JHU. French President Emmanuel Macron declared a state of health emergency and imposed a curfew on virus hot spots earlier this month. Spain on Wednesday became the first Western European nation to top 1 million cases.

Oct 22, 2020 - Health

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!